Editors' Pick
Papers: 17 Jul 2015 - 24 Jul 2015
Editors' Pick
Episode 49 with Dr. Hugh Rosen on sphingosine 1-phosphate receptor modulators
Links to articles and other resources mentioned in Episode 49
Methods
Comparative Effectiveness Research on the Treatment of Multiple Sclerosis: Request for Information from the Patient-Centered Outcomes Research Institute
Request For Information (RFI) Released: July 13, 2015
Information Due: July 27, 2015
For more information, email: info@pcori.org
Opportunity Snapshot
The Patient Centered Outcomes Research Institute has released a request for information (RFI) to identify patient registries and research groups with established cohorts of patients for potential collaborative
MS TRIAL ALERT: Investigators Recruiting for Study of Oral Laquinimod in Primary-Progressive MS
Summary: Investigators at sites worldwide are recruiting 375 people with primary-progressive MS for a Phase 2 clinical trial comparing oral laquinimod (Teva Pharmaceuticals), an experimental compound that is believed to modify immune function, with inactive placebo in 375 people with primary-progressive MS. The study is funded by Teva Pharmaceutical Industries Ltd.
Rationale: There are currently no disease-modifying therapies specifically approved for treating the primary-progressive form of MS.
MS Trial Alert: Investigators Recruiting 1200 People with Relapsing MS For Study of Oral RPC1063
Summary: Investigators worldwide are recruiting 1200 people with relapsing MS for a study testing the effectiveness of two different doses of the experimental oral therapy RPC1063 (Receptos, Inc.) versus Avonex® (interferon beta-1a, Biogen Inc.) at reducing the rate of relapses. The study, called the Sunbeam Study, is funded by Receptos, Inc.
Rationale: RPC1063 is a selective sphingosine 1-phosphate receptor modulator (similar to the mode of action of Gilenya® [fingolimod, Novartis International AG]).
Papers: 10 Jul 2015 - 17 Jul 2015
Episode 48 with Dr. Bruce Cree on the EPIC, CLIMB, and SUMMIT clinical studies
Links to articles and other resources mentioned in Episode 48
Methods